This is a routine tax-withholding sale by a director following equity vesting. No material signal for the stock. Monitor for any larger or unplanned insider sales in the coming weeks, but this filing alone does not warrant action.
How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Jun 3 $7.09entry
- T+1 · 6mo ago +3.10%α +2.70% · $7.31
- T+5 · 5mo ago −0.85%α +2.97% · $7.03
- T+20 · 5mo ago +29.76%α +30.76% · $9.20
- T+60 · 3mo ago −10.30%α −12.79% · $6.36
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Charles Divita III, a director of Teladoc Health, filed a Form 144 notice of intent to sell 19,132 shares of common stock, valued at approximately $145,920. The shares were acquired on June 1, 2026, through restricted stock vesting as compensation. This is a routine insider sale to cover tax obligations from equity vesting, not a discretionary market sale.
Key Facts
- Director Charles Divita III filed a Form 144 to sell 19,132 shares of TDOC common stock.
- Estimated sale value is approximately $145,920 based on the filing date.
- Shares were acquired on June 1, 2026, via restricted stock vesting as compensation.
- The sale is intended to cover tax obligations from the vesting of an equity award.
- The filing represents intent to sell; the actual sale may not occur.
Financial Impact
Approximately $145,920 in shares (19,132 shares) to be sold, representing a small fraction of the director's holdings and less than 0.01% of TDOC's $1.4B market cap.
Risk Factors
- Insider selling for tax purposes is routine and not indicative of bearish sentiment.
- No risk of material dilution or negative signal from this filing.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001959173-26-004279 |
| Document: 0001959173-26-004279-index.html | 0001959173-26-004279 |
| Document: 0001959173-26-004279.txt | 0001959173-26-004279 |
Track record
24 reports on TDOC
3 of 3 bullish or bearish reports moved the stock their way by T+1. Best: +2.52% at T+1 after the Oct 28, 2026 report. 3 of 3 went positive at some point.
Filters
- Nov 16, 2026today SC 13G Neutral 3/10 Entry $8.60 Now $8.70 +1.22% settles Nov 17
- Nov 6, 202610d ago 144 Neutral 3/10 Entry $8.77 to $8.98 Now $8.70 −0.80% ▲ +2.39% +0.03% vs SPY
- Nov 3, 202613d ago 3 / PRESS-RELEASE Neutral 2/10 Entry $9.70 to $9.41 Now $8.70 −10.31% ▼ −2.99% +1.42% vs SPY
- Nov 3, 202614d ago PTAB Trial Neutral 3/10 Entry $8.89 to $9.70 Now $8.70 −2.14% ▲ +9.11% +7.46% vs SPY
- Oct 28, 202619d ago Press Release Bearish 6/10 No price data
- Oct 28, 202619d ago 8-K Bearish 6/10 Entry $8.73 to $8.51 Now $8.70 +0.34% ▲ +2.52% +0.75% vs SPY
- Oct 28, 202620d ago PTAB Trial Neutral 3/10 Entry $8.73 to $8.51 Now $8.70 −0.34% ▼ −2.52% −0.75% vs SPY
- Oct 8, 20265w ago SC 13G Neutral 3/10 Entry $5.54 to $5.77 Now $8.70 +57.04% ▲ +4.15% +3.55% vs SPY
- Sep 25, 20267w ago 8-K Neutral 3/10 Entry $6.09 to $5.89 Now $8.70 +42.86% ▼ −3.28% −2.54% vs SPY
- Sep 11, 20269w ago 144 Neutral 2/10 Entry $6.16 to $6.50 Now $8.70 +41.23% ▲ +5.52% +5.97% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers